asco: new treatment (t-dm1) for her2-positive advanced breast cancer?
Published 12 years ago • 4.4K plays • Length 4:19Download video MP4
Download video MP3
Similar videos
-
3:07
breast cancer drug t-dm1 shows promise in trial
-
3:21
how breast cancer treatment kadcyla (t-dm1) works
-
2:02
katherine trial: t-dm1 cuts her2-positve invasive breast cancer recurrence
-
2:52
"empowering insights: her2 early breast cancer & t-dm1 treatment update"
-
0:59
asco 2012 - t-dm1 for her 2 positive advanced breast cancer
-
4:10
what’s new with her2-neu inhibition
-
13:34
systemic therapy for advanced her2-positive breast cancer guideline update
-
3:21
kadcyla ( t-dm1 ) an amazing new breast cancer drug
-
3:21
breast cancer drug - trastuzumab emtansine - mechanism of action
-
3:32
enhertu: breakthrough hope for her2 positive cancers
-
33:34
sharing my her2 breast cancer diagnosis story at 35 years old
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
6:40
her2 breast cancer: managing patients on t-dm1
-
0:56
t-dm1 as part of our standard of care with residual her 2 disease
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
2:21
tucatinib with t-dm1 for her2-positive metastatic breast cancer
-
1:21
katherine trial tests trastuzumab emtansine in breast cancer recurrence
-
0:58
enhertu therapy: a powerful new cancer treatment
-
2:00
dr. esteva discusses t-dm1 in her2-positive breast cancer
-
1:55
advances in treatments for her2-positive metastatic breast cancer
-
0:56
dr. jhaveri discusses the utility of t-dm1 in the neoadjuvant setting